D
Nurix Therapeutics, Inc. NRIX
$13.59 $0.403.03%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

11/30/2024 08/31/2024 05/31/2024 02/29/2024 11/30/2023
Revenue -29.15% -17.76% 2.25% 94.02% 99.31%
Total Other Revenue -- -- -- -- --
Total Revenue -29.15% -17.76% 2.25% 94.02% 99.31%
Cost of Revenue 17.17% 10.01% 5.96% 3.29% 2.52%
Gross Profit -48.97% -26.31% -7.78% 22.71% 23.11%
SG&A Expenses 7.09% 10.89% 10.58% 16.30% 12.91%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 15.31% 10.17% 6.79% 5.52% 4.29%
Operating Income -37.38% -22.27% -8.47% 14.53% 15.67%
Income Before Tax -34.28% -18.83% -4.69% 18.99% 20.19%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -34.47% -19.01% -4.81% 18.94% 20.19%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -34.47% -19.01% -4.81% 18.94% 20.19%
EBIT -37.38% -22.27% -8.47% 14.53% 15.67%
EBITDA -37.65% -22.31% -7.92% 15.77% 17.13%
EPS Basic -9.10% -5.94% 1.63% 24.90% 28.94%
Normalized Basic EPS -8.93% -5.78% 1.73% 24.94% 28.94%
EPS Diluted -9.10% -5.94% 1.63% 24.90% 28.94%
Normalized Diluted EPS -8.93% -5.78% 1.73% 24.94% 28.94%
Average Basic Shares Outstanding 23.52% 12.98% 6.21% 7.11% 11.80%
Average Diluted Shares Outstanding 23.52% 12.98% 6.21% 7.11% 11.80%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings